The swift-striking cuts caused by the sequestration and the longer term dwindling of budgets at US science funding agencies are taking a toll, as a majority of US scientists are now receiving less federal funding than they were three years ago, and nearly 20 percent of them are considering seeking science work abroad, Huffington Post's Sam Stein writes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.